Search Results
AMD 070 25mg 25mg | Purity Not Available
Adooq Bioscience
AMD 070 10mg 10mg | Purity Not Available
Adooq Bioscience
Moxonidine 100mg 100mg | Purity Not Available
Adooq Bioscience
Moxonidine is a new-generation centrally-acting antihypertensive drug. It may have a role when thiazides, beta-blockers, ACE inhibitors and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistance syndrome, apparently independent of blood pressure reduction.
More Information Supplier PageMoxonidine 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Moxonidine is a new-generation centrally-acting antihypertensive drug. It may have a role when thiazides, beta-blockers, ACE inhibitors and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistance syndrome, apparently independent of blood pressure reduction.
More Information Supplier PageBMS-509744 50mg 50mg | Purity Not Available
Adooq Bioscience
The ITK inhibitor BMS-509744 disrupts several aspects of HIV replication.
More Information Supplier PageBMS-509744 5mg 5mg | Purity Not Available
Adooq Bioscience
The ITK inhibitor BMS-509744 disrupts several aspects of HIV replication.
More Information Supplier PageBMS-509744 25mg 25mg | Purity Not Available
Adooq Bioscience
The ITK inhibitor BMS-509744 disrupts several aspects of HIV replication.
More Information Supplier PageBMS-509744 10mg 10mg | Purity Not Available
Adooq Bioscience
The ITK inhibitor BMS-509744 disrupts several aspects of HIV replication.
More Information Supplier PageBMS 345541 50mg 50mg | Purity Not Available
Adooq Bioscience
BMS 345541 is a cell-permeable and highly selective IKB kinase (IKK) inhibitor that binds at allosteric site of the enzyme and blocks NF-kB-dependent transcription in mice.
More Information Supplier Page